神州细胞定增获证监会同意注册批复

Core Viewpoint - Shenzhou Cell has received approval from the China Securities Regulatory Commission (CSRC) for its stock issuance to specific investors, aiming to raise up to 900 million yuan for liquidity support [1] Group 1 - The company announced the approval on January 5, indicating a significant step in its capital-raising efforts [1] - The total amount to be raised from the stock issuance is capped at 900 million yuan, which includes the principal amount [1] - After deducting issuance costs, the entire raised amount is intended to be used for supplementing the company's working capital [1]